New drug combo shows promise in early cancer trial
NCT ID NCT04354246
First seen May 14, 2026 · Last updated May 30, 2026 · Updated 3 times
Summary
This early-stage study tested the safety of a new drug called COM902, given alone or with other drugs, in 94 people with advanced cancers like ovarian, lung, or colon cancer that had stopped responding to standard treatments. The main goal was to find a safe dose and check for side effects. While the drug may help control the cancer, it is not expected to be a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Florida Cancer Specialists
Sarasota, Florida, 34230, United States
-
Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
MD Anderson Cancer Center.
Houston, Texas, 77030, United States
-
Mary Crowley Cancer Research
Dallas, Texas, 75230, United States
-
Massachusetts General Hospital.
Boston, Massachusetts, 02114, United States
-
START Midwest.
Grand Rapids, Michigan, 49503, United States
-
The Ohio State University Comprehensive Cancer Center.
Columbus, Ohio, 43210, United States
-
The START Center for Cancer Care.
San Antonio, Texas, 78229, United States
-
The University of Tennessee WEST Cancer Center.
Memphis, Tennessee, 38138, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.